Alternative Name: | Type I collagen, Procollagen type I C-terminal propeptide, PICP |
|
Clone: | 4 |
|
Host: | Mouse |
|
Isotype: | IgG1κ |
|
Immunogen: | Purified human PICP from second trimester amniotic fluid. |
|
UniProt ID: | P02452 |
|
GenBank ID: | 1277 |
|
Source: | From culture supernatant. |
|
Species reactivity: | Human
|
|
Specificity: | Specific for for native PICP from amniotic fluid. |
|
Applications: | ELISA
|
|
Purity Detail: | Protein A/G-purified. |
|
Formulation: | Liquid. In 0.01M phosphate buffer, pH 7.4, containing 0.5M sodium chloride and 15mM sodium azide. |
|
Shipping: | Blue Ice Not Frozen |
|
Long Term Storage: | +4°C |
|
Scientific Background: | Type I collagen is present in connective tissue and bone where it makes up about 90% of the organic matrix. Type I collagen is produced from type-I procollagen by the proteolytic cleavage of N- and C-telopeptides, which are released into the circulation. The propeptides can be measured in serum as markers of the production of type-I collagen. Elevated values of these propeptides are found in serum from patients with various metabolic or malignant bone diseases. Procollagen type I C-terminal propeptide (PICP) has a molecular mass of approximately 100kDa. Its normal concentration in serum depends on age and sex. |
|
Regulatory Status: | RUO - Research Use Only |
|